The findings of the Stratified Medicine Paediatrics (SMPaeds1) programme, published in the journal Cancer Discovery, ...

BC Platforms has announced that it has appointed Mukhtar Ahmed as its new Chief Executive Officer (CEO). Ahmed brings over ...

A new UK study has highlighted the critical role of GP data in understanding atrial fibrillation (AF), the most common form ...

NHS England has launched its first-ever breast cancer awareness campaign aimed at highlighting the benefits of screening for ...

The University of Bath has received a £3.5 million Wellcome grant to study cognitive decline and premature brain ageing in ...

Scientists in Cambridge have developed a new ‘super test’ for prostate cancer to improve screening, diagnosis and ...

The US Food and Drug Administration (FDA) has approved Deciphera Pharmaceuticals’ Romvimza (vimseltinib) to treat adults with ...

Telix Pharmaceuticals has announced that the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has approved the ...

After two years of treatment with bimekizumab, 53.1% of patients experienced mild disease compared to none at baseline.

Amlenetug received Orphan Drug Designation (ODD) from the US FDA in April 2024, the EMA in May 2021 and SAKIGAKE designation ...

Baxter International has appointed Heather Knight, who has been leading the company’s Medical Products and Therapies unit, as ...

Carbogen Amcis has appointed Stephan Fritschi, who is currently serving as the company’s Chief Alliance Officer and Deputy ...